NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EarlyDiagnostics

EarlyDiagnostics

Private
Agoura Hills, CaliforniaHealthcare & Life Scienceshttps://earlydx.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$3.99M

Company Overview

EarlyDiagnostics is a healthcare technology company that provides accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

liquid biopsyearly cancer detectioncell-free DNAcfDNAmulti-cancer early detectionMCEDDNA methylation analysisbiomarker discoverycompanion diagnosticsCDxbioinformatics platformprecision medicinetissue of originnon-invasive diagnosticsCLIA laboratory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EarlyDiagnostics Comparables

Compare EarlyDiagnostics with similar companies based on industry and business-model similarity.

EarlyDiagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acuamark Diagnostics
83%
Adela
81%
Singlera Genomics Inc.
80%

EarlyDiagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantSep 1, 2022

Key People

Founding team and executive leadership

Jasmine Zhou

Co-Founder And Co-CEO

Founding Team

Xiaohui Ni

Scientist CTO

Executive Team

EarlyDiagnostics Investors

Notable investors and investment history

EarlyDiagnostics investors
InvestorRounds
NIH RADxGrant
Alpha EdisonSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 2, 4x the trailing average.

  • Jan 8, 2026

    Monthly visitors grew 298% MoM to 1.3K.

EarlyDiagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EarlyDiagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EarlyDiagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAgoura Hills, California
Employee Range8
Year Founded2017
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.